Then this will really crack you up... posted on 9/1/14. Wasn't long after this he started his rants about dilution and the additional 1B authorized shares.

Quote:

---

I've decided to vote YES

- while I would like nothing more than to see greater substantial milestone accomplished / publicised before the ASM, timelines are forever changing, especially in the startup biotech arena. It basically comes down to a couple of considerations, to name a just few:

trust
performance
management
BOD/BOA
competancy
vision
inventory
delivery
execution

I've had numerous opportunities to pull and sell my 2-Mil. shares with a substantial net gain, but decided long ago to remain "all in." I see no sound reason now to change my mind. If anything, I'm more convinced than ever AMBS is a burgeoning biotech superstar in the making.

All the Best, JP

---

http://investorshangout.com/post/view?id=1940942